Sydney Lupkin
Stories
-
Where patients live matters for access to gene therapy
Gene therapies have the potential to cure some diseases, but they are extraordinarily expensive. Location can also be a big hurdle for patients seeking this specialized care.
-
FDA reverses course on Moderna flu shot
A little more than a week after the FDA rattled the biotech industry by rejecting Moderna's mRNA flu vaccine without even reviewing the application, the agency changed course. But there's a catch.
-
What the FDA's rejection of Moderna's flu shot means for the future of vaccines
The Food and Drug Administration rejected Moderna's new flu shot. This raises questions about what it means for the future of vaccine development.
-
White House unveils TrumpRx website for medication discounts
Under Trump administration deals to lower drug prices, pharmaceutical companies are offering some of their drugs at discounted prices through a new website called TrumpRx.gov.
-
Gene therapies are out of reach for many who need them to beat diseases
Gene therapy drugs have the potential to cure some diseases, but some have a price tag of over a million dollars. Who gets access to them and who doesn't?
-
Trump struck deals with 16 drug companies. But they're still raising prices this year
All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their prices for 2026.
-
Wegovy obesity pill now available at pharmacies
Drugmaker Novo Nordisk said the prescription medicine can be found at a range of pharmacies, including CVS and Costco, as well as some telehealth providers.
-
What's ahead for the weight-loss drugs known as GLP-1s in 2026
There's a new pill and new ways to pay for the weight-loss drugs known as GLP-1s.
-
When porch pirates steal medicine instead of holiday gifts
Mail theft can happen around the holidays, but sometimes, instead of getting a new iPad, the thief swipes a mail order medicine. Here's what to do about it.
-
FDA to raise hurdles for vaccines, faulting COVID shots for 10 kids' deaths
Food and Drug Administration officials say they will ratchet up requirements for vaccine studies, citing concerns about COVID shots for kids. But public health experts question the agency's analysis.
